Skip to content

Effects of a Program to Reduce Fatigue Among Sepsis Survivors: A Randomized Controlled Trial

Effects of Program Reducing Fatigue among Sepsis Survivors

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240329002
Enrollment
68
Registered
2024-03-29
Start date
2024-08-26
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis Survivors Sepsis Survivors Program Fatigue

Interventions

The program that contains exercise, anxiety management, provide nutrition knowledge and promotion sleep with sleep hygiene.,Standard care is receiving normal advice by nurse before discharge.
Experimental Behavioral,No Intervention No treatment
Program to reduce fatigue,Standard care

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patient aged 18 - 85 years who treated sepsis for more than 48 hours with normal vital signs and no symptoms and signs of multiple organ dysfunction according to qSOFA criteria. 2. The patient has no physical abnormalities. (with bone injuries and arthritis, osteoarthritis, gout, etc.) 3. Patient aged 60 years and over after taking the Mini Cog test and receiving a score greater than or equal to 3 again. 4. Patient who has experience symptoms of fatigue, evaluated by using the Piper Fatigue Scale-12 questionnaire, moderate or higher or with a PFS-12 score greater than equal to 4 points. 5. Able to communicate by speaking, reading, and writing Thai. 6. The patient or caregiver has a smart phone. and can use the LINE application.

Exclusion criteria

Exclusion criteria: 1. The patient has co-morbidities that cause fatigue easily which does not occur after sepsis, such as cancer undergoing chemotherapy or radiotherapy, HIV patients with a CD4 level lower than 350 cubic millimeters, chronic obstructive pulmonary disease, asthma, kidney failure stage 4 or higher, liver disease with Child Pugh Score C, anemia with hemoglobin less than 7 g/dl, malnutrition with serum albumin less than 2, heart failure. Have had a history of being infected with coronavirus 19, which was accompanied by fatigue. 2. Patients with neurological and brain disorders, such as spinal cord injuries, or had surgery related to the nervous system and brain. 3. Patients diagnosed with psychiatric disorders such as schizophrenia, bipolar disorder or severe depression. 4. Terminally ill patients or bedridden patients

Design outcomes

Primary

MeasureTime frame
Fatigue severity score at baseline, 2 weeks after intervention and 4 weeks after intervention Piper Fatigue Scale 12

Secondary

MeasureTime frame
N/A N/A N/A

Countries

Thailand

Contacts

Public ContactWimolrat Puwarawuttipanit

Faculty of Nursing, Mahidol University

wimolrat.puw@mahidol.ac.th024197466

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026